| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |